Servier and Insilico Sign $888M AI Oncology Discovery Deal
Servier and Insilico Medicine struck a multi-program AI oncology discovery collaboration worth up to $888M, including $32M upfront. A concise analysis of roles, strategy and realistic impact.
Servier and Insilico Sign $888M AI Oncology Discovery Deal Read More »










